Source: FinanzNachrichten

Clementia: Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Voting Agreements With Two Additional Significant Shareholders

MONTREAL, March 7, 2019 /PRNewswire/ -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) is pleased to announce that it has obtained an interim order from the Québec Superior Court in connection with...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more